ArticleFrontiers in medicine2021

Case Report: Two Rare Cases of Complete Metabolic Response to Crizotinib in Patients With Rearranged ROS1 and ALK Metastatic Non-small Lung Cancer.

Karim Amrane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.